A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients
Clinical trial NCT04458298 · TERMINATED
Trial details
- NCT number
- NCT04458298
- Sponsor
- Ashvattha Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2022-08-12
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.